A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

August 17, 2026

Study Completion Date

June 14, 2027

Conditions
Systemic Sclerosis (SSc)
Interventions
COMBINATION_PRODUCT

Efgartigimod PH20 SC

Subcutaneous efgartigimod PH20 SC given by prefilled syringe

OTHER

Placebo PH20 SC

Subcutaneous placebo PH20 SC given by prefilled syringe

Trial Locations (50)

1090

RECRUITING

UZ Brussel, Jette

1680

RECRUITING

Diagnostic Consultative Center Convex EOOD, Sofia

2100

RECRUITING

Rigshospitalet, Copenhagen

4002

RECRUITING

Medical Center Artmed OOD, Plovdiv

7632

RECRUITING

Pecsi Tudomanyegyetem, Klinika Kozpont, Bor, Nemikortani es Onkodermatologiai Klinika, Pécs

8023

RECRUITING

Hospital Del Mar, Barcelona

9000

RECRUITING

UZ Gent, Ghent

RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

11152

RECRUITING

Military Medical Academy, Belgrade

11172

RECRUITING

Sf.Maria Clinical Hospital, Bucharest

14004

RECRUITING

C.H. Regional Reina Sofia, Córdoba

19104

RECRUITING

Perelman Center for Advanced Medicine, Philadelphia

20132

RECRUITING

Ospedale San Raffaele S.r.l., Milan

20475

RECRUITING

Dr I Cantacuzino Clinical Hospital, Bucharest

21000

RECRUITING

University Hospital of Split, Split

21044

RECRUITING

Thomas Jefferson University, Columbia

21224

RECRUITING

Johns Hopkins Asthma and Allergy Center, Baltimore

23000

RECRUITING

General Hospital Zadar, Zadar

31000

RECRUITING

Clinical Hospital Centre Osijek, Osijek

32429

RECRUITING

Mühlenkreiskliniken - Johannes Wesling Klinikum Minden, Minden

33324

RECRUITING

IRIS Research and Development LLC, Plantation

48109

RECRUITING

University of Michigan Hospital, Ann Arbor

50161

RECRUITING

Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas

75014

RECRUITING

AP-HP - Hôpital Cochin - Port-Royal, site Cochin, Paris

80131

RECRUITING

Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli

4810345

RECRUITING

Centro de especialidades médicas Vanguardia, Temuco

8320000

RECRUITING

BIOCINETIC Ltda, Santiago

8330034

RECRUITING

Centro de Investigaciones Clinicas UC (CICUC), Santiago

85032-9306

RECRUITING

Arizona Arthritis and Rheumatology Associates, Phoenix

C1046AAQ

RECRUITING

Aprillus Asistencia e Investigacion, Buenos Aires

C1405BFN

RECRUITING

Instituto de Investigación Clínica TyT, Buenos Aires

C1426ABP

RECRUITING

Consultorios Médicos Dr. Doreski - Fundacion Respirar, Buenos Aires

T4000IHE

RECRUITING

Clínica Mayo de U.M.C.B. S.R.L, San Miguel de Tucumán

T4000IKJ

RECRUITING

Centro de Investigaciones Médicas Tucumán, San Miguel de Tucumán

140 59

RECRUITING

Revmatologicky Ustav, Prague

265 04

RECRUITING

University General Hospital of Patras, Pátrai

546 36

RECRUITING

Euromedica Kianous Stavros, Thessaloniki

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

LT-92288

RECRUITING

Klaipeda Hospital, Affiliate of Klaipeda University Hospital, Klaipėda

30-002

RECRUITING

Malopolskie Badania Kliniczne, Krakow

20-607

RECRUITING

Zespol Poradni Specjalistycznych REUMED, Lublin

67-100

RECRUITING

Twoja Przychodnia NCM, Nowa Sól

00-874

RECRUITING

MICS Centrum Medyczne Warszawa, Warsaw

53-224

RECRUITING

Niepubliczny Zaklad Opieki Zdrowotnej Biogenes, Wroclaw

1349-019

RECRUITING

ULS de Lisboa Ocidental, EPE - Hospital Egas Moniz, Lisbon

1649-035

RECRUITING

ULS de Santa Maria,EPE - Hospital de Santa Maria, Lisbon

4434-502

RECRUITING

ULS de Gaia/Espinho, EPE - Unidade I, Vila Nova de Gaia

00936

RECRUITING

The Alliance Medical Sciences Campus, San Juan

08208

RECRUITING

Corporacio Sanitaria Parc Tauli, Sabadell

LU4 0DZ

RECRUITING

Luton and Dunstable University Hospital, Luton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT06655155 - A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis | Biotech Hunter | Biotech Hunter